Published in Clin Pharmacokinet on March 01, 1994
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A (1999) 1.51
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) (2006) 1.48
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol (2005) 1.27
Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord (2010) 1.23
Effect of fluoxetine on pharmacokinetics of ritonavir. Antimicrob Agents Chemother (1998) 1.13
Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. Clin Pharmacol Ther (2014) 1.04
The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2009) 0.96
Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol (1999) 0.96
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol (1999) 0.96
Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol (1999) 0.95
Block by fluoxetine of volume-regulated anion channels. Br J Pharmacol (1999) 0.91
Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech (2005) 0.88
Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells. J Biol Chem (2012) 0.87
Pharmacokinetics of fluoxetine in rhesus macaques following multiple routes of administration. Pharmacology (2011) 0.86
Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress. Neuropharmacology (2015) 0.84
Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions. Eur J Clin Pharmacol (2004) 0.83
Predictive validity of a non-induced mouse model of compulsive-like behavior. Behav Brain Res (2011) 0.82
Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects. Br J Clin Pharmacol (2001) 0.80
Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine. PLoS One (2014) 0.79
Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure. Pflugers Arch (2015) 0.78
Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression. Daru (2013) 0.78
Modulation of 5-HT4 receptor function in the rat isolated ileum by fluoxetine: the involvement of endogenous 5-hydroxytryptamine. Br J Pharmacol (2002) 0.78
Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study. Curr Ther Res Clin Exp (2010) 0.77
Population PK modelling and simulation based on fluoxetine and norfluoxetine concentrations in milk: a milk concentration-based prediction model. Br J Clin Pharmacol (2014) 0.77
Fluoxetine Decreases the Proliferation and Adipogenic Differentiation of Human Adipose-Derived Stem Cells. Int J Mol Sci (2015) 0.76
Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.). J Am Assoc Lab Anim Sci (2014) 0.75
Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response. Sci Rep (2016) 0.75
QbD-Driven Development and Validation of a Bioanalytical LC-MS Method for Quantification of Fluoxetine in Human Plasma. J Chromatogr Sci (2016) 0.75
Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry (1993) 1.08
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. Int J Clin Pharmacol Res (1989) 0.95
Prescribing second-generation antipsychotics and the evolving standard of care in Italy. Pharmacopsychiatry (2002) 0.89
Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia. Health Policy (2000) 0.86
The costs of pharmacological treatment for major depression. The Italian Prospective Multicentre Observational Incidence-Based Study. Pharmacoeconomics (2000) 0.80
Alternative prophylactic treatments to lithium in bipolar disorders. Clin Neuropharmacol (1990) 0.79
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline. Int Clin Psychopharmacol (1989) 0.79
Anthropometric aspects of body seated in school. Work (2012) 0.79
Physiopathologic role of microlithiasis in gallstone pancreatitis. Surg Gynecol Obstet (1987) 0.78
Factors affecting the clinical response to haloperidol therapy in schizophrenia. Clin Neuropharmacol (1990) 0.77
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine. Pharmacopsychiatry (1989) 0.76
[Laparocele in the aged]. Acta Biomed Ateneo Parmense (1990) 0.76
Mental health care in Italy: organisational structure, routine clinical activity and costs of a community psychiatric service in Lombardy region. Int J Soc Psychiatry (2000) 0.76
From Bassini to tension-free mesh hernia repair. Review of 1409 consecutive cases. G Chir (1998) 0.75
Cholecystectomy for acute cholecystitis: timing of operation, bacteriologic aspects, and postoperative course. Am J Surg (1984) 0.75
Dexamethasone suppression test in positive and negative schizophrenia. Psychiatry Res (1989) 0.75
The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directions. J Clin Psychiatry (1993) 0.75
[Melanosis of the colon. Considerations on 101 cases]. Minerva Dietol Gastroenterol (1987) 0.75
[CEA and breast neoplasms: application of a personal method for determination of CEA in the clinical study of 242 patients (author's transl)]. Bull Cancer (1979) 0.75
[Costs of psychiatric services: a study performed at a public mental center in the Lombardy Region, Italy]. Epidemiol Psichiatr Soc (1997) 0.75
[Evaluation of long-term results in 254 patients surgically treated by gastric resection for peptic ulcer]. Chir Ital (1982) 0.75
Urinary sodium levels related to jaundice duration in the assessment of postoperative risk of hepatorenal syndrome in elderly patients undergoing surgery for biliary obstruction. Ital J Surg Sci (1989) 0.75
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels. Prog Neuropsychopharmacol Biol Psychiatry (1990) 0.75
[Clinical features of 27 cases of ischemic colitis (author's transl)]. Ateneo Parmense Acta Biomed (1980) 0.75
[On the vascularization of the anorectal segment]. Ateneo Parmense Acta Biomed (1975) 0.75
Papillitis: a critical appraisal based on intraoperative radiomanometric evaluation. Ital J Surg Sci (1987) 0.75
[Hemobilia and hemoperitoneum (discussion of an unusual clinical case)]. Chir Ital (1977) 0.75
[Preliminary observations on the behavior of serum ferritin in female patients with breast cancer at various stages of the disease]. Acta Biomed Ateneo Parmense (1982) 0.75
[Peroperative antibiotic therapy in biliary surgical diseases]. Acta Biomed Ateneo Parmense (1982) 0.75
Hydroxyproline and zinc excretion in patients with neoplastic breast disease. Int Surg (1982) 0.75
Dysplasia-carcinoma sequence in diminutive polyps of the large bowel. Ital J Surg Sci (1988) 0.75
[Gastric polyps. Considerations on 162 endoscopic polypectomies]. Minerva Chir (1987) 0.75
Total parenteral nutrition (TPN) in the management of post-operative alimentary tract fistulas. Acta Biomed Ateneo Parmense (1982) 0.75
Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy. Int J Psychiatry Clin Pract (1997) 0.75
Technetium-99m HIDA hepatobiliary scanning in evaluation of afferent loop syndrome. Am J Surg (1984) 0.75
[Prognostic significance of CEA in breast cancers]. Bull Cancer (1982) 0.75
[Carcinoma of the breast in young women]. G Ital Oncol (1989) 0.75
[Local recurrences after mastectomy for cancer (author's transl)]. Ateneo Parmense Acta Biomed (1980) 0.75